Literature DB >> 20606118

Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival.

Jeffrey M Testani1, Jennifer Chen, Brian D McCauley, Stephen E Kimmel, Richard P Shannon.   

Abstract

BACKGROUND: Overly aggressive diuresis leading to intravascular volume depletion has been proposed as a cause for worsening renal function during the treatment of decompensated heart failure. If diuresis occurs at a rate greater than extravascular fluid can refill the intravascular space, the concentration of such intravascular substances as hemoglobin and plasma proteins increases. We hypothesized that hemoconcentration would be associated with worsening renal function and possibly would provide insight into the relationship between aggressive decongestion and outcomes. METHODS AND
RESULTS: Subjects in the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness trial limited data set with a baseline/discharge pair of hematocrit, albumin, or total protein values were included (336 patients). Baseline-to-discharge increases in these parameters were evaluated, and patients with >or=2 in the top tertile were considered to have evidence of hemoconcentration. The group experiencing hemoconcentration received higher doses of loop diuretics, lost more weight/fluid, and had greater reductions in filling pressures (P<0.05 for all). Hemoconcentration was strongly associated with worsening renal function (odds ratio, 5.3; P<0.001), whereas changes in right atrial pressure (P=0.36) and pulmonary capillary wedge pressure (P=0.53) were not. Patients with hemoconcentration had significantly lower 180-day mortality (hazard ratio, 0.31; P=0.013). This relationship persisted after adjustment for baseline characteristics (hazard ratio, 0.16; P=0.001).
CONCLUSIONS: Hemoconcentration is significantly associated with measures of aggressive fluid removal and deterioration in renal function. Despite this relationship, hemoconcentration is associated with substantially improved survival. These observations raise the question of whether aggressive decongestion, even in the setting of worsening renal function, can positively affect survival.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606118      PMCID: PMC3025294          DOI: 10.1161/CIRCULATIONAHA.109.933275

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

Review 1.  Congestion in acute heart failure syndromes: an essential target of evaluation and treatment.

Authors:  Mihai Gheorghiade; Gerasimos Filippatos; Leonardo De Luca; John Burnett
Journal:  Am J Med       Date:  2006-12       Impact factor: 4.965

2.  Assessment of fluid responsiveness in mechanically ventilated cardiac surgical patients.

Authors:  C Wiesenack; C Fiegl; A Keyser; C Prasser; C Keyl
Journal:  Eur J Anaesthesiol       Date:  2005-09       Impact factor: 4.330

3.  Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate.

Authors:  Andrew Boyle; Paul A Sobotka
Journal:  J Card Fail       Date:  2006-05       Impact factor: 5.712

4.  Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH).

Authors:  Martin R Cowie; Michel Komajda; Tarita Murray-Thomas; Jonathan Underwood; Barry Ticho
Journal:  Eur Heart J       Date:  2006-04-19       Impact factor: 29.983

5.  Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.

Authors:  Cynthia Binanay; Robert M Califf; Vic Hasselblad; Christopher M O'Connor; Monica R Shah; George Sopko; Lynne W Stevenson; Gary S Francis; Carl V Leier; Leslie W Miller
Journal:  JAMA       Date:  2005-10-05       Impact factor: 56.272

Review 6.  Assessment of indices of preload and volume responsiveness.

Authors:  Michael R Pinsky; Jean-Louise Teboul
Journal:  Curr Opin Crit Care       Date:  2005-06       Impact factor: 3.687

7.  Relation of loop diuretic dose to mortality in advanced heart failure.

Authors:  Shervin Eshaghian; Tamara B Horwich; Gregg C Fonarow
Journal:  Am J Cardiol       Date:  2006-04-27       Impact factor: 2.778

8.  Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

9.  Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.

Authors:  Vic Hasselblad; Wendy Gattis Stough; Monica R Shah; Yuliya Lokhnygina; Christopher M O'Connor; Robert M Califf; Kirkwood F Adams
Journal:  Eur J Heart Fail       Date:  2007-08-24       Impact factor: 15.534

Review 10.  Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy.

Authors:  Leonardo De Luca; Gregg C Fonarow; Kirkwood F Adams; Alexandre Mebazaa; Luigi Tavazzi; Karl Swedberg; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2007-06       Impact factor: 4.654

View more
  197 in total

1.  What have we learned about loop diuretics in acute decompensated heart failure? The DOSE trial.

Authors:  Dmitry Shchekochikhin; JoAnn Lindenfeld
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

2.  Congestion is the driving force behind heart failure.

Authors:  Maya Guglin
Journal:  Curr Heart Fail Rep       Date:  2012-09

3.  Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactions.

Authors:  Jeffrey M Testani; Brian D McCauley; Jennifer Chen; Michael Shumski; Richard P Shannon
Journal:  Cardiology       Date:  2010-08-03       Impact factor: 1.869

4.  Management of the cardiorenal syndrome in acute heart failure.

Authors:  Valentina Lazzarini; G Michael Felker
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

Review 5.  Pathophysiology and clinical evaluation of acute heart failure.

Authors:  Robert J Mentz; Christopher M O'Connor
Journal:  Nat Rev Cardiol       Date:  2015-09-15       Impact factor: 32.419

Review 6.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

7.  Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure.

Authors:  Meredith A Brisco; Steven G Coca; Jennifer Chen; Anjali Tiku Owens; Brian D McCauley; Stephen E Kimmel; Jeffrey M Testani
Journal:  Circ Heart Fail       Date:  2013-01-16       Impact factor: 8.790

8.  Influence of age-related versus non-age-related renal dysfunction on survival in patients with left ventricular dysfunction.

Authors:  Jeffrey M Testani; Meredith A Brisco; Gang Han; Olga Laur; Alexander J Kula; Susan J Cheng; Wai Hong Wilson Tang; Chirag R Parikh
Journal:  Am J Cardiol       Date:  2013-10-03       Impact factor: 2.778

Review 9.  Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Authors:  Veli-Pekka Harjola; Wilfried Mullens; Marek Banaszewski; Johann Bauersachs; Hans-Peter Brunner-La Rocca; Ovidiu Chioncel; Sean P Collins; Wolfram Doehner; Gerasimos S Filippatos; Andreas J Flammer; Valentin Fuhrmann; Mitja Lainscak; Johan Lassus; Matthieu Legrand; Josep Masip; Christian Mueller; Zoltán Papp; John Parissis; Elke Platz; Alain Rudiger; Frank Ruschitzka; Andreas Schäfer; Petar M Seferovic; Hadi Skouri; Mehmet Birhan Yilmaz; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2017-05-30       Impact factor: 15.534

10.  Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.

Authors:  Horng H Chen; Omar F AbouEzzeddine; Kevin J Anstrom; Michael M Givertz; Bradley A Bart; G Michael Felker; Adrian F Hernandez; Kerry L Lee; Eugene Braunwald; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2013-09-01       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.